04 March is World Obesity Day

Every year at the beginning of March, there is a day dedicated to the topic of obesity as World Obesity Day. Certainly, this is not a holiday for those affected, but at least it is the day when there is a good reason to think about obesity in general and the stigmatisation associated with it in particular.

This year the focus is “Male Obesity”. This cannot simply be categorised as “gluttony” or “self-indulgence”. Male obesity has as many causes as it has manifestations. It primarily affects men from middle age onwards, who (like women) are undergoing a particular type of metabolic change.

Particularly as we get older, the body strives to store food reserves as fat reserves for developmental reasons, in order to provide for possible shortages. Especially for men who consume fewer calories than they take in due to their occupation or limited exercise, this quickly leads to unwanted excess weight. Organic processes in particular play an important role here, which cannot be “switched off” so easily.

In a special video, I personally addressed the importance of World Obesity Day. This is also due to the fact that obesity is now more common worldwide than malnutrition. The actual problem is mainly to be observed in the western industrialised countries, since it is precisely here that there is an ever-increasing surplus of food – practically at all times.

The obesity rate in the USA, for example, is around 35-40 percent of the population, which is a fact that should not be underestimated. This means an overweight of at least 20 kilograms, or a BMI of 30 or more. This is also the case despite the surgical intervention options, although these methods in particular can now be classified as very safe and successful. Nevertheless, the rate of surgical interventions needed in this particular area is far too low.

World Obesity Day is not simply about informing the public and professional colleagues accordingly. Rather, I see it as important to educate people about the modern treatment options of bariatric surgery. The primary aim is always to help patients according to their individual starting situation.

Information on the topic of obesity

It is important to understand that obesity is always associated with concomitant diseases. Diabetes, high blood pressure, sleep apnoea, high cholesterol – all these manifest themselves in the environment of obesity. But there is also another aspect that has emerged, especially in recent years. The point is that people who are overweight are simply stigmatised. At school, at work and even in private life, overweight people are described as lazy, fat, greedy, careless and lazy about exercise. This puts additional stress on those affected and does not help to tackle the problem in a targeted and conscious way. Significant overweight has been defined as a disease since 2013 at the latest. This puts morbid obesity in the same category as diseases such as diabetes, high blood pressure and many other chronic diseases.

The stigmatisation of obesity is extremely dangerous for patients, as they then withdraw and cannot address their actual problem in a targeted and active way. Professional treatment, counselling and support is the surest way out of obesity.

World Obesity Day can help break down prejudices

Everyone is challenged to exercise some restraint in their contact with morbidly obese people, both in their choice of words and in their behaviour. To this end, World Obesity Day can create better awareness. The problem should not only be addressed on this day of the year. But such a day can help to create more sensitivity for the problems of overweight people instead of leaving them to their fate with stigmatisation and devaluation.

Why specifically “men who are overweight”?

Yes, women also suffer from morbid obesity. But men do it in a special way. There are now “curvy models” for women, but not for men. And men by nature already tend to eat the slightly larger portions, even if that seems to be gradually declining. The world view was and still is such that a belly is always subconsciously associated with prosperity. Also in modern industrial societies. The dangers are usually conscious, but are only realised when they are actually there.

In addition, after a certain stage of life at the latest, men do not have this special view of their appearance that many women have. The actual problem is not recognised, or is recognised only very late, and is then gladly accepted as natural. This means that they don’t have to go to the doctor and the obesity surgeon is an unknown quantity for many of those affected. Therefore, men in particular must be sensitised to actively face this problem. World Obesity Day provides an excellent opportunity to do this.

Swiss1Chirurgie informs patients and endocrinologists

New set of rules for obesity surgery

From 01 January 2021, it will be possible to have obesity surgery from a BMI of 30+ with concomitant type 2 diabetes. One of the prerequisites is that diabetes can no longer be safely controlled by conventional means. Only a few specialist clinics are authorised to perform such operations. This also includes the clinics of Swiss1Chirurgie, which offer such procedures in the Helvetia Holding AG network. Learn more about the BAG’s decision.

Overweight surgery possible from BMI 30 with diabetes as of 2021

Being overweight is not something to be trifled with. All those affected know this just as well as we do as medical specialists. For years, the experts at Swiss1Chirurgie have been observing the development of obesity in modern industrialised countries. It is becoming increasingly clear that the proportion of overweight people is growing. Associated with this are not only the individual restrictions and complaints. Healthy societies quickly become sick societies through an oversupply of food at any time in any place and correspondingly wrong nutritional behaviour, whose lack is above all abundance.

So far, health insurers and medical organisations, together with politicians in Switzerland, have agreed that surgical interventions to reduce weight are only possible for a BMI of 35 or higher and are financed accordingly. It was completely ignored that a BMI of 35 or more is already an enormously high value, which is already associated with numerous secondary diseases and complaints. Such concomitant diseases not only complicate the lives of the patients themselves, but are often also a clear obstacle in the preparation and implementation of necessary obesity surgery.

From 2021 the threshold is BMI 30

In accordance with the interventions of the medical specialists and a close observation of the development, the politicians together with the medical profession have decided to lower the threshold value for bariatric surgery in the context of obesity surgery now to a BMI of 30, provided that the patients are affected by diabetes at the same time.

This long overdue decision will benefit patients who, despite being diagnosed with obesity and the corresponding symptoms, were previously not included in the group of patients for whom obesity surgery was an option.

This means that a wide range of conditions closely related to obesity can be treated much sooner and necessary and desired surgical interventions can also be carried out. This will have a lasting impact on the quality of life of people with a BMI over 30 and diabetes, and ultimately reduce the proportion of severely overweight people, along with the social and economic costs.

Advantages especially for humans

The decisive advantages of this decision now lie above all with those people who, with a BMI of 30 or more and diabetes, are already clearly affected by morbid obesity. Now the suffering of these people can be significantly shortened. This is also because it obviously does not make sense to wait for an enormously high BMI of 35 and more until a surgical intervention for weight reduction is made possible by the regulations.

A major advantage of this decision is that the extent of overweight and the associated concomitant and secondary diseases such as diabetes, cardiovascular diseases and arthrosis can be significantly reduced. The psychological suffering can also be significantly shortened and patients with a BMI of 30 or more with diabetes may now place themselves in the hands of the experienced specialists in obesity surgery. The Swiss1Chirurgie clinics are among the specialist medical clinics that will be authorised to perform surgical procedures to reduce excess weight from a BMI of 30 with diabetes from 01.01.2021.

Determine your BMI here and find out whether and under what conditions you belong to the circle of possible candidates for obesity surgery.

TO THE BMI CALCULATOR

In addition, we recommend that all severely overweight people contact a Swiss1Chirurgie clinic. By doing so, you will take the first step towards a better, healthier future in 2021 and use the possibilities of modern medicine to improve your life.

Contact Swiss1Chirurgie here.

4th Symposium of Helvetius Holding AG at the Talent Campus Bodensee in Kreuzlingen

The 4th Helvetius Holding AG symposium will take place on 22 October 2021 from 18:00. Core topics of the public event are diabetes and obesity as well as liver diseases with the effects on personal health. The subject area will be expanded by interesting lectures on motivation in recreational sports and on liver fasting with Hepafast.

In addition to Dr. med. Jörg Zehetner, nutritional physicians Dr. med. Hardy Walle and Dr. med. Tilmann Schmitz as well as football and coaching legend Martin Andermatt will lead through the exciting topics.

We expect your registration for the free event under Registration Kreuzlingen – Helvetius Holding AG.

More information is available in the article and under Streaming – Live Events Kreuzlingen – Die Helvetius Holding AG.

Symposium of Helvetius Holding AG at the Talent Campus Bodensee Kreuzlingen

An event full of specialist medical and social topics with networking opportunities

With its 4th symposium at the Talent Campus Bodensee in Kreuzlingen, Helvetius Holding AG is heading for the highlight of this year’s lecture series.

With Dr. med. Jörg Zehetner (Professor USC), Dr. med. Hardy Walle (nutritional physician), Martin Andermatt (trainer and football legend) as well as Dr. med. Tilmann Schmitz (nutritional physician), nationally and internationally recognised personalities will be on stage and will speak on focal points of medical research, healthy nutrition, motivation and sport.

The core topics of the medical specialist subjects are

  • “Belching, obesity and diabetes – recognising connections” and
  • “Fatty liver and obesity – liver fasting with Hepafast”.

In addition, the highly interesting event deals with topics on motivation and healthy lifestyles in everyday life, but also answers questions that arise for every concerned and interested participant.

In addition to specialists from the various fields, well-known and successful entrepreneurs and personalities of public interest also meet here to exchange opinions and network.

This will provide interesting opportunities for participants in the event to expand knowledge, build skills and make valuable contacts.

The 4th Helvetius Holding AG symposium is open to all interested and registered participants free of charge.

Date: 22 October 2021, 6:00 p.m. at the Talent Campus Bodensee in Kreuzlingen.

Please note that participation in the symposium is only possible after prior registration.

You can easily register at Registration Kreuzlingen – Die Helvetius Holding AG.

Please feel free to consider this information as a personal invitation and register to participate in the event. We look forward to meeting you or seeing you again at the 4th Helvetius Holding AG symposium at the Talent Campus Bodensee in Kreuzlingen.

Fatty liver and diabetes – the connections

Dr. med. Michaela Neagu FMH Gastroenterology and Internal Medicine GGP Bern

In a lecture by the gastroenterological group practice GGP Bern AG (a company of Helvetius Holding AG), the gastroenterologist Dr. med. Michaela Neagu illustrates the connections between fatty liver and diabetes. Following the lecture, it becomes clear that fatty liver and diabetes form a vicious circle in which both diseases trigger and drive each other. In addition to diagnostics and the effects on overall health, the lecture also opens up a clear picture of how the course of the disease can be successfully influenced and, in the best case, reversed. We have made the lecture by Dr Michaela Neagu available in text form, but also as a video lecture and as a PowerPoint presentation. You can find out more here.

Chapter selection : Start video Select menu bar at the bottom right or dots !
Full screen : Start video Select menu bar bottom right and !

Fatty liver disease and diabetes mellitus – are there correlations?

The experts at Helvetius Holding AG clarify

In a lecture by GGP Bern AG, Dr. med. Michaela Neagu presented the connections between fatty liver disease and diabetes mellitus. This is less about medical jargon and more about educating people about what a fatty liver is, what it means for people’s lives and whether there is a connection to diabetes mellitus.

Dr Michaela Neagu is a specialist in gastroenterology (gastrointestinal diseases) and general internal medicine in the Gastroenterology Group Practice Bern, a partner of Helvetius Holding AG, and has extensive experience and expertise in her specialist field.

In her lecture, Michaela Neagu, MD, highlights the clear connections between fatty liver and diabetes mellitus.

The fatty liver disease

Basically, a distinction is made between alcoholic fatty liver disease and non-alcoholic (metabolic) fatty liver disease. As the different names suggest, one form of fatty liver disease is related to excessive alcohol consumption, the other has nothing to do with alcohol consumption. In addition, there are manifestations such as viral liver diseases, autoimmune diseases, iron storage disorders and other conditions that promote fatty liver disease or make it possible in the first place.

Worldwide, about 25 percent of the population is affected by fatty liver disease. This makes fatty liver the most common liver disease of all. Among diabetics themselves, about 30 to 40 percent have a fatty liver. Also, about half of patients with severe dyslipidemia suffer from fatty liver disease.

How does a fatty liver develop?

A fatty liver occurs when the capacity of the liver cells to absorb fat is exceeded. This causes fat to be deposited in the liver itself, which can no longer be broken down by the liver. The accumulation of fat in the liver cells causes these cells to become inflamed and then send out messenger substances that inhibit the supply of insulin to the liver. Eventually, a kind of insulin resistance develops, so that insulin cannot work in the body as nature intended.

As a result, hyperglycaemia occurs in the body. This sends out a stimulus that causes even more insulin to be produced. The increased insulin level then further leads to increased fat absorption, fat synthesis and fat storage as well. This creates a cycle of action that deposits more and more fat in the liver, but also generally increases fat storage in the body far beyond normal levels.

What do people affected by fatty liver notice?

It is sobering to note that about half of all those affected live practically asymptomatic and accordingly do not worry at all about their liver health, for example. On the one hand, this may have a calming effect, but on the other hand, it is an alarm signal that effective therapeutic interventions only start late, usually very late.

Some patients experience general but rather non-specific fatigue. A certain faintness and perhaps once undifferentiated slight pain in the upper abdomen indicate that a serious condition could be present here. Mostly, however, this is not taken seriously by the patients themselves.

As a result, in most cases the fatty liver remains an incidental finding that only comes to light during the treatment of other diseases. This could be, for example, elevated liver values during a health check or visible changes in the liver during a standard ultrasound examination.

In general, there is a risk that untreated fatty liver can progress to cirrhosis. At the latest then, those affected realise that their liver is sick. Typical signs are then the well-known large water belly, certain bypass circuits in the organism and other signs come very late, however. In practice, everything is possible with the clinical picture of fatty liver, from no symptoms to severe and dangerous courses of the disease.

Between 50 and 90 percent of people with fatty liver are obese, i.e. clearly overweight. Signs of a metabolic syndrome are recognisable.

How can a fatty liver be diagnosed with certainty?

A few years ago, biopsy was the method of choice when the condition of the liver cells needed to be determined more precisely. To do this, a needle is inserted directly into the organ and a small tissue sample is taken. This tissue sample can then be further examined for fatty liver cells.

Thanks to advances in medical technology, we can now diagnose fatty liver without a biopsy in 90 percent of cases. With different imaging methods such as ultrasound or computer tomography, absolutely painless examinations can be carried out today without interfering with the body. Thanks to the excellent presentation, the fat content in the liver can be determined comparatively well with reliable values.

The basis for the evaluation of the ultrasound examinations is, for example, a comparison of liver and kidney tissue. If both organs are healthy, they have approximately the same structure and colour in the image. If the kidney tissue appears darker than that of the liver, then the lighter parts in the liver indicate fat deposits. In this way, a fatty liver can already be recognised with a fairly high degree of certainty.

If the specialists then decide to take a tissue sample, usually to exclude or detect additional liver diseases, the differences become even clearer. A healthy liver consists of neatly arranged and clearly differentiated cells. In fatty liver, the disturbance of the cell architecture due to the fatty deposits is clearly visible. This becomes even more obvious in the case of a pronounced fatty liver with infected cells.

What is the path to fatty liver

From a healthy liver to a fatty liver always takes time and certain circumstances. Various unfavourable factors cause fat storage in the liver cells, which can then further lead to infection in the liver itself. It doesn’t have to be, but it can be. However, when such an infection takes place, a certain remodelling in the connective tissue is driven forward, which can lead to complete scarring of the liver if left untreated. Then the stage of liver cirrhosis has already been reached. Liver cirrhosis, in turn, is a favourable factor for the development of liver cancer. This applies to about two percent of those affected. But even when liver cirrhosis has not yet been diagnosed, more and more cases of liver cancer in fatty liver are becoming known. And in the USA, fatty liver is now considered the most common reason for liver transplantation.

A look at diabetes mellitus

Usually we are talking about diabetes here. This is diagnosed when chronically elevated sugar levels are found in the blood. The body is over-sugared, so to speak. The factors that cause high blood glucose levels are a reduction in the effect of insulin and, in the course of time, often an insulin deficiency.

Currently, about six percent of the world’s population, including children, are affected by diabetes. In children, type 1 diabetes is mostly observed. With the increase in morbid obesity, also in children, type 2 is also becoming more common. Diabetes can be diagnosed in a very reliable and uncomplicated way in various test procedures.

What does diabetes mellitus mean for people’s lives?

The presence of diabetes mellitus is actually associated with serious risks and consequences for the health and life of those affected. One problem is the damage to the small veins. This mainly affects the kidneys, the retina of the eye and the nervous system. The range extends from relatively mild kidney problems to complete kidney failure requiring dialysis. In the case of retinal diseases, such disorders can lead to blindness due to diabetes mellitus. In terms of damage to the nervous system, there is a loss of certain sensory impressions, which can manifest itself, for example, in patients no longer being able to feel the ground beneath their feet. Problems with coordination and spatial position change are also observed. Gastrointestinal disorders with diarrhoea and other symptoms are also reported. Cardiac arrhythmias can complete the picture.

In addition to damage to the small veins, damage to the large veins is also a consequence of diabetes mellitus. Particularly worth mentioning here are coronary heart diseases. At least here, the risk of diabetes patients is significantly higher compared to the normal population. For diabetics, this risk can be assessed as about twice as high. A full 75 percent of diabetics die from a cardiovascular event.

The risk of suffering a stroke is also about 2.5 times higher than in the comparison group of people without diabetes. A circulatory disorder, especially in the legs, has a risk of 4.5 times more than in the comparison group. The diabetic foot is well known, which is caused by precisely these circulatory disorders and can even lead to the necessary amputation.

Diabetes mellitus also generally increases the risk of infection in relation to practically all infectious diseases.

The relationship of fatty liver and diabetes mellitus

What is special about the relationship between fatty liver disease and diabetes mellitus is the fact that both diseases can be mutual and reciprocal triggers as well as consequences of the other disease. This means: fatty liver patients are or often become diabetics and diabetics often suffer from fatty liver. So there is a causal relationship between fatty liver and diabetes.

Let us imagine a possible course of events: An initially physically completely healthy and normal person begins to gain weight for various reasons. Fat tissue increases and at some point the ability to store fat is exhausted. This then leads to a veritable flooding of the entire organism with free fatty acids. At some point, the organism becomes resistant to the effect of insulin and hyperglycaemia occurs. Now the question arises: Where to put the sugar?

Some of the free fatty acids are deposited in the liver cells, where they lead to the fatty liver already described. This significantly limits the liver’s ability to metabolise healthy fats. In addition, there is an increasingly pronounced insulin residual tendency, which in turn affects blood sugar in the interaction and ultimately leads to type 2 diabetes. Other effects are always included here, such as high blood pressure, disorders of the function of the pancreas, etc.

The mutual condition of fatty liver and diabetes creates a vicious circle that is difficult to break, and then only with radical methodology.

What can be done?

At least up to a body mass index BMI of 30, maximum 35, it is still possible to take countermeasures and something should be done actively. It is worth noting that the fatty liver is reversible, i.e. it can also be regressed. Even if liver infection has already occurred, the process can still be reversed. Timely action is crucial. If cirrhosis of the liver has already occurred, it can hardly be stopped. Nevertheless, even then, consistent lifestyle adjustments and regular check-ups should be aimed at preventing further liver damage.

The way back to a healthy liver is always through a reduction in body weight and a corresponding reduction in the over-fatness of the organism. Even a five percent reduction in body weight leads to a relevant defatting of the liver.

With seven to ten percent weight loss, infections in the liver or incipient scarring of the liver tissue can also be reversed. These are encouraging facts that have been sufficiently tested and researched.

Several factors are crucial for weight loss. This starts with a significant reduction in calorie intake and continues with healthy and regular exercise. A period of at least eight weeks, but usually considerably more, is to be set. The closest possible consultation and care by specialists is highly advisable, as other risk factors must also be observed and ruled out. This applies especially to cardiovascular risks.

Toxic foods such as alcohol, drinks with a high fructose content and nicotine should be avoided at all costs.

You can watch the entire lecture by Dr. med. Michaela Neagu with a lot of additional interesting information and further questions and answers here in the video lecture.

A PowerPoint presentation on the topic illustrates and complements the lecture.

Hardy Walle, MD, at the 4th Helvetius Holding AG symposium

The focus of the 4th Helvetius Holding AG symposium at the Talent Campus Bodensee in Kreuzlingen on 22 October 2021 was the topic of liver health. All speakers agreed that fatty liver is a major cause of many diseases of civilisation in modern society. What could be more natural than to invite the co-founder of liver fasting with HEPAFAST® to the event? In his impressive and scientifically supported lecture, the nutritional physician and internist Dr. med. Hardy Walle not only established the connection between non-alcoholic fatty liver and diabetes, but at the same time proved the previously unattained effectiveness of the BODYMED HEPAFAST® concept for liver fasting. In the detailed report you will learn a lot about the topic and receive further information about liver fasting with HEPAFAST®.


Lecture:


Interview:


Liver Fasting with HEPAFAST® – The Effective Way to Liver Health

A healthy liver has extensive effects on a person’s state of health and has a lasting impact on many functions, especially metabolism. Hardy Walle, MD, was a very special guest at the 4th Helvetius Holding AG symposium at the Talent Campus Bodensee in Kreuzlingen.

Hardy Walle, MD, together with Prof. Nicolai Worm, is known as the founder of liver fasting with HEPAFAST®. The system, specially developed by both nutritional physicians, has been proven to have a positive effect on liver health and offers excellent opportunities for keeping the liver healthy. Even after severe liver diseases, but also used preventively, liver fasting according to Dr. Walle brings about the full functionality of the liver and thus contributes decisively to a healthy lifestyle. In his lecture, the internist and nutritionist and founder of BODYMED AG will present liver fasting with all its effects on liver detoxification and interactions on a healthy life.

Why liver fasting and what is special about it?

The core of the considerations here are the differences of liver fasting compared to other diet programmes. The starting point is provided by data on the development of overweight and the spread of obesity in Germany. It is clear that obesity with a BMI over 25 has spread significantly in the last 20 years or so. This applies especially to obesity with a BMI of 30 and above. In Germany, it is currently assumed that more than half of the total population is overweight. This leads to the logical conclusion that being overweight is now considered the normal thing to be. At the same time, almost a quarter of the population with a BMI of over 30 can be classified as obese. When we talk about obesity, we clearly mean obesity. This also makes it clear that in the case of overweight we are essentially looking at the ratio of fat to total weight. Last but not least, it is also about body fat distribution, i.e. where the fat is located on the body.

It is also interesting to note in the assessment of obesity that with the increase in overweight people, the proportion of people with type 2 diabetes is also increasing at more or less the same rate. It is interesting to note that diabetes mellitus type 2 has nothing to do with people’s age, as was once assumed. People of any age can be affected by type 2 diabetes, with obesity playing a particularly decisive role. Also among young people. So there is a clear correlation between obesity and secondary diseases.

It is all the more astonishing that light overweight is repeatedly communicated as not being so bad and that there are specialist journalists who believe that people “with light to medium overweight live the longest and get the fewest diseases …”. What is often meant is that the connection between BMI and mortality is not so significant.

Accordingly, there is a study in which, for once, not the BMI but the body shape, here specifically the waist circumference, was taken as a yardstick for the assessment among high-risk patients. Surprisingly, in the test group of around 15,000 volunteers, the group that turned out to be more mortal when measured within five years was the one that only had a BMI of 22. However, a closer look revealed that this group showed exactly the same waist circumference as the group of obese volunteers with a BMI 30. The waist circumference was 101 centimetres in each case. However, while the BMI 22 volunteer only had a belly, the BMI 30 volunteer also had a lot of fat distributed over his body.

The volunteers with the highest mortality were quite thin except in the abdominal area and had hardly any muscles. This also explains the relatively low weight despite a 101 abdominal girth. If we know that muscles also have a protective factor, then the increased mortality in this comparison group can also be explained by the lack of a protective function of the muscles. If one follows this thought, then it becomes clear that the ratio of muscle mass to fat mass is of great importance.

Conversely, this also means that BMI alone does not indicate how muscle and fat are distributed. So looking at BMI alone distorts reality, although it can provide initial signals. So it is not the BMI alone that is decisive. It definitely depends on the abdominal girth. Nevertheless, most people may know approximately their weight, but hardly anyone can quantify their abdominal circumference relatively clearly. An increased abdominal girth (women over 88 cm, men over 102 cm) is a clear risk factor for heart attacks, for example. Here, the risk increases by a factor of 4.5.

While there are tablets against high blood pressure, you can only influence your abdominal girth with your own activity. And this is exactly where liver fasting comes in. It is not one-sidedly about weight reduction, but quite clearly about belly reduction. In conclusion, this means getting rid of belly fat. But not only the fat around the organs, but especially the fat in the organs. This refers to the liver, pancreas, kidneys and, more broadly, the heart and bone structure.

Belly fat is the dangerous fat

It must be clear that the liver, for example, is not made to store fat. For that, there is rather the subcutaneous fat tissue. Belly fat has clear potential dangers. These show up as risk factors for

  • Diabetes type 2
  • High blood pressure
  • Heart attack
  • Stroke
  • Potency disorders
  • Circulatory disorders
  • Dementia

All these can be consequences of too much belly fat. In principle, this is also where bariatric surgery comes in, which can certainly also ensure rapid defatting of the liver with obesity surgery.

A renowned German researcher puts the basic statement in a nutshell: “Without a fatty liver, there is no diabetes”. (Professor Norbert Stefan, Tübingen)

In most cases, it is the fatty liver that is the trigger and cause of many secondary diseases. Knowing this is important, because only then can cause, symptom, effect be clearly determined, which ultimately has clear implications for the right therapy.

Non-alcoholic fatty liver (NAFLD) can be considered the cause of many manifestations of pathological processes. For example, for infections caused by free radicals, for gout caused by increased uric acid, increased blood sugar levels, lipid metabolism disorders, high blood pressure or for thrombosis and finally the metabolic syndrome. Liver cancer is not negligible here and is increasing explosively, especially in the USA with the large proportion of obese people.

Generally speaking, 30 to 40 percent of the total population in Germany is affected by a fatty liver. In the overweight group, this proportion is already 70 percent. If we take only type 2 diabetics, around 90 percent of those affected are “equipped” with a fatty liver. From this, the connections between fatty liver, obesity and diabetes become even clearer. This makes non-alcoholic fatty liver one of the most common liver diseases. But even 15 percent of outwardly slim people are affected by a fatty liver.

How can non-alcoholic fatty liver be diagnosed?

Basically, a non-alcoholic fatty liver is a fatty liver that is not caused by alcohol or other causes. In industrialised nations, it is considered the most frequently diagnosed liver disease. Just as no typical complaints can be detected, pure laboratory values alone hardly provide a meaningful basis.

We speak of a non-alcoholic fatty liver when more than 5.5 to 6 percent of the liver cells are fatty. This portion cannot be detected on ultrasound alone. Here, something can only be seen from a fatty degeneration of about 20 percent. The most accurate diagnosis can be made with a liver biopsy, but this is unlikely to be the first step in the diagnosis.

One value has become established in Europe. We are talking about the Fatty Liver Index (FLI). This results in a validated algorithmic numerical value that is also well suited for progress monitoring. With the FLI, a fatty liver can be diagnosed quite well and reliably.

Statistics show that mortality is significantly increased in fatty liver patients. Fatty liver is therefore not a cosmetic problem or characterised solely by increased blood fat levels etc., it is a real high-risk factor in terms of life expectancy and mortality.

Main causes for the development of a fatty liver

In the past, the causes of fatty liver were simply summarised by saying that people eat too much fat. The real cause, however, is an excess of ingested carbohydrates. Another cause may be the intake of a lot of fructose, i.e. fruit sugar. The main fatsifier of the liver is even found here.

Carbohydrates are broken down into sugar in the body. At the same time, the pancreas produces insulin. However, insulin has two effects: On the one hand, insulin ensures that the sugar reaches the muscles, and on the other hand, some of the sugar reaches the liver to regulate the blood sugar level there. If the liver releases too much sugar, insulin slows down this release. In addition, insulin ensures that excess sugar is stored in fat tissue.

Under certain conditions, organs begin to no longer respond adequately to insulin. A kind of insulin resistance develops. Then the liver is also no longer properly regulated by insulin. In the prediabetic course, the blood glucose level then rises even in fasting volunteers. Such a process develops slowly, so that in individual cases diabetes only develops after ten to twelve years. This process can even take up to 20 years. During this time, the liver is less and less regulated by insulin and becomes increasingly fatty. This process is accelerated when the subcutaneous fat tissue cannot form any more fat cells because it is literally flooded with fat. More and more fat and sugar move in the blood. Out of a natural reaction, the organism then builds up additional fat stores in the liver.

In the long term, however, it is not only the liver that becomes fatty, but also the pancreas, the kidneys, the muscles, the heart and even the hypothalamus in the brain.

The basics of liver fasting

The basic idea behind liver fasting is to simply go backwards from the rather unhealthy path taken so far. The most important step is the defatting of the liver. This usually requires a strict diet.

This means:

  • less than 1’000 kcal per day
  • few carbohydrates
  • Absorption of high quality protein
  • Only “good” fats if possible
  • special liver-active agents and dietary fibres

All this is combined in HEPAFAST® in a well-tolerated and easy-to-use formula. The programme is easy to implement in everyday life. It is easy to digest, fills you up and meets all the requirements of a good liver-healthy diet.

HEPAFAST® is taken three times a day, prepared with a milk product. In addition, twice daily vegetable preparations with a total of maximum 200 kcal per day. This means one HEPAFAST® preparation for breakfast, one HEPAFAST® and one vegetable preparation for lunch and one HEPAFAST® and one vegetable preparation for dinner. No more, but also no less.

Due to this suitability for everyday use, there are hardly any dropouts in the HEPAFAST® liver detoxification programme, which significantly increases the success rate.

The reset for the metabolism causes:

  • Normalisation of the function of the pancreas and the insulin sensitivity of the liver
  • Promotion of insulin secretion
  • Normalisation of glucagon regulation
  • reduces the uncontrolled release of glucose from the liver into the blood
  • improves metabolism and facilitates weight loss

For whom is liver fasting useful?

In principle, liver fasting with HEPAFAST® is useful for all patients with the following constellation:

  • Fatty liver (NAFDL, NASH)
  • metabolic syndrome
  • Type 2 diabetes
  • Overweight and obesity
  • Lipometabolic disorders
  • High blood pressure
  • preventive as a “metabolic cure” for the prevention of diseases
  • prior to bariatric surgery

It makes no sense to wait until you have a BMI of 30 or an abdominal circumference of well over 100 centimetres. You can always start a liver fast with HEPAFAST® even without such symptoms.

Further information

You can watch the entire live video stream with Hardy Walle, MD, with additional research results, statistics and a concrete case study here.

In addition, you will also find further contributions from Helvetius Holding AG’s specialist conferences here.

Belching, obesity and diabetes – recognising connections

Only those who recognise the connection between reflux, obesity and diabetes can find the right therapeutic approach. This is what emerges from the expert lecture by Dr. Med. Jörg Zehetner, Professor (USC), about which you can read the full article here.

Continue reading